MX2009004775A - Nuevos compuestos y metodos para su produccion. - Google Patents

Nuevos compuestos y metodos para su produccion.

Info

Publication number
MX2009004775A
MX2009004775A MX2009004775A MX2009004775A MX2009004775A MX 2009004775 A MX2009004775 A MX 2009004775A MX 2009004775 A MX2009004775 A MX 2009004775A MX 2009004775 A MX2009004775 A MX 2009004775A MX 2009004775 A MX2009004775 A MX 2009004775A
Authority
MX
Mexico
Prior art keywords
production
diseases
methods
novel compounds
cancer
Prior art date
Application number
MX2009004775A
Other languages
English (en)
Inventor
Christine Martin
Original Assignee
Biotica Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0622342.4A external-priority patent/GB0622342D0/en
Priority claimed from GB0720875A external-priority patent/GB0720875D0/en
Application filed by Biotica Tech Ltd filed Critical Biotica Tech Ltd
Publication of MX2009004775A publication Critical patent/MX2009004775A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a análogos de ansamicina que son útiles, por ejemplo en el tratamiento de cáncer, malignidades de la célula B, paludismo, infección por hongos, enfermedad del sistema nervioso central y enfermedades neurodegenerativas, enfermedades dependientes de angiogénesis, enfermedades autoinmunitarias o un pretratamiento profiláctico para cáncer. La presente invención también proporciona métodos para la producción de estos compuestos y su uso en medicina.
MX2009004775A 2006-11-09 2007-11-09 Nuevos compuestos y metodos para su produccion. MX2009004775A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0622342.4A GB0622342D0 (en) 2006-11-09 2006-11-09 Novel compounds and methods for their production
GB0720875A GB0720875D0 (en) 2007-10-24 2007-10-24 Novel compounds and methods for their production
PCT/GB2007/050679 WO2008056188A2 (en) 2006-11-09 2007-11-09 Novel compounds and methods for their production

Publications (1)

Publication Number Publication Date
MX2009004775A true MX2009004775A (es) 2009-05-21

Family

ID=39362724

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004775A MX2009004775A (es) 2006-11-09 2007-11-09 Nuevos compuestos y metodos para su produccion.

Country Status (10)

Country Link
US (1) US8492370B2 (es)
EP (1) EP1973883B1 (es)
JP (1) JP2010509306A (es)
KR (1) KR20090075856A (es)
AU (1) AU2007319014B2 (es)
BR (1) BRPI0718564A2 (es)
CA (1) CA2669047A1 (es)
ES (1) ES2389740T3 (es)
MX (1) MX2009004775A (es)
WO (1) WO2008056188A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2121957A4 (en) * 2007-01-26 2010-11-10 Kosan Biosciences Inc MACROLACTAMES OBTAINED BY MODIFIED BIOSYNTHESIS
KR101097850B1 (ko) 2009-02-24 2011-12-23 한국생명공학연구원 젤다나마이신 생합성 조절유전자 변이주 및 이를 이용한 젤다나마이신 생산방법
CN117695374A (zh) * 2024-01-25 2024-03-15 超越健康科技(浙江)有限公司 一种用于治疗帕金森病的生物药物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2127457A1 (en) * 1992-01-06 1993-07-22 Walter P. Cullen Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone
AU2003217393B8 (en) 2002-02-08 2009-06-25 Conforma Therapeutics Corporation Ansamycins having improved pharmacological and biological properties
DK1716119T3 (da) * 2003-12-23 2013-06-10 Infinity Discovery Inc Analoger af benzoquinonholdige ansamyciner til behandling af cancer
WO2005061461A1 (ja) 2003-12-24 2005-07-07 Kyowa Hakko Kogyo Co., Ltd. ヒートショックプロテイン90（hsp90）ファミリー蛋白質阻害剤
US7608611B2 (en) * 2005-03-11 2009-10-27 The Regents Of The University Of Colorado Hsp90 inhibitors, methods of making and uses therefor
AU2006263111A1 (en) * 2005-06-29 2007-01-04 Kyowa Hakko Kirin Co., Ltd. Benzenoid ansamycin derivative
CA2628728A1 (en) * 2005-12-24 2007-07-05 Biotica Technology Ltd. 21-deoxymacbecin analogues useful as antitumor agents
CN101012196A (zh) * 2006-12-27 2007-08-08 中国人民解放军军事医学科学院毒物药物研究所 芳香化格尔德霉素类衍生物及其制备方法和用途
EP2121957A4 (en) * 2007-01-26 2010-11-10 Kosan Biosciences Inc MACROLACTAMES OBTAINED BY MODIFIED BIOSYNTHESIS

Also Published As

Publication number Publication date
US8492370B2 (en) 2013-07-23
AU2007319014A1 (en) 2008-05-15
WO2008056188A3 (en) 2008-07-31
JP2010509306A (ja) 2010-03-25
CA2669047A1 (en) 2008-05-15
BRPI0718564A2 (pt) 2014-03-11
AU2007319014B2 (en) 2013-03-28
KR20090075856A (ko) 2009-07-09
ES2389740T3 (es) 2012-10-31
US20110021481A1 (en) 2011-01-27
EP1973883B1 (en) 2012-07-11
EP1973883A2 (en) 2008-10-01
WO2008056188A2 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
JO2931B1 (en) Double-substituted phthalazin compounds as antagonists of the cell-specific factor pathway
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
HK1139930A1 (en) Cyclopamine lactam analogs and methods of use thereof
PT2069324E (pt) Amino piridina fundida como inibidor da hsp90
UA102065C2 (en) Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
TW200716646A (en) (S)-N-methylnaltrexone
NZ708727A (en) Conjugate compounds
MX2011011342A (es) Compuestos de vinil indazolilo.
TN2012000108A1 (en) Sustituted (heteroarylmethyl) thiohydantoins as anticancer drugs
TW200508201A (en) Novel process for the preparation of roflumilast
WO2008095086A3 (en) Topiramate plus naltrexone for the treatment of addictive disorders
TN2011000647A1 (en) Fused imidazoles and compositions comprising them for the treatment of parasitic diseases such as e.g. malaria
UA102515C2 (ru) Новая лекарственная форма
TN2011000166A1 (en) Disubstituted phthalazine hedgehog pathway antagonists
EP2416795A4 (en) COGNITIVE DECLINE INHIBITORS
MX2009000991A (es) Uso de escina.
AU2013212209A8 (en) (1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
WO2007128829A3 (en) 18,21-didesoxymacbecin derivatives for the treatment of cancer
MX2009004775A (es) Nuevos compuestos y metodos para su produccion.
MX2009009361A (es) Nueva forma de dosificacion.
TW200517144A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
MX2009004777A (es) Derivados de 18,21-didsesoximacbecina para el tratamiento de cancer.
EP2029615B8 (en) A process for the preparation of an oxaliplatin
WO2007113266A3 (en) Novel compounds and methods for their production

Legal Events

Date Code Title Description
FG Grant or registration